BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21282547)

  • 1. Loss of Epstein-Barr virus-encoded RNA expression in cutaneous dissemination of natural killer/T-cell lymphoma.
    Teo WL; Tan SY
    J Clin Oncol; 2011 Apr; 29(12):e342-3. PubMed ID: 21282547
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary Pancreatic Natural Killer/T-Cell Lymphoma.
    Chon HK; Choi KH; Kim TH
    Pancreas; 2020 Mar; 49(3):e21-e23. PubMed ID: 32168254
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary Cutaneous Peripheral T-Cell Lymphoma With Follicular Helper T-Cell Phenotype: Report of 2 Epstein-Barr Virus-Positive Cases.
    Chiang CT; Chuang SS; Lin HF; Li WH; Chiang YY; Chen BJ
    Am J Dermatopathol; 2023 Feb; 45(2):73-80. PubMed ID: 36669068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rare Case of Cutaneous Intravascular NK/T-Cell Lymphoma.
    Jia Y; Pei D; Yang X; Min W; Song L
    Clin Lab; 2021 Jul; 67(7):. PubMed ID: 34258975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Case of Epstein-Barr Virus-Positive T-Cell Lymphoma in the Skin of an Immunocompromised Patient.
    van Eijk LE; Koldijk MJ; van Kester MS; Diepstra A; Diercks GFH
    Am J Dermatopathol; 2022 Feb; 44(2):e19-e22. PubMed ID: 35076433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus DNA measurement in skin tumor lesions might be a sensitive diagnostic marker of recurrence in patients with nasal-type extranodal NK/T-cell lymphoma: A case report.
    Yokota N; Kondo M; Matsushima Y; Habe K; Yamanaka K
    J Dermatol; 2023 Sep; 50(9):e285-e286. PubMed ID: 36938658
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical analysis of 20 cases of cutaneous extranodal NK/T-Cell lymphoma.
    Wang D; Min S; Lin X; Jiang G
    Indian J Dermatol Venereol Leprol; 2023; 89(5):718-724. PubMed ID: 37067109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous extranodal natural killer/T cell lymphoma with delayed expression of CD56.
    Kobayashi A; Goto H; Negishi-Asano A; Sowa-Osako J; Tanaka S; Ohe C; Kohashi K; Tsuruta D; Tateishi C
    Eur J Dermatol; 2023 Dec; 33(6):705-706. PubMed ID: 38465562
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of the immune microenvironment in the indolent form of primary cutaneous extranodal natural killer/T-cell lymphoma: A case report.
    Maeda R; Minowa T; Kato J; Horimoto K; Sato S; Hirohashi Y; Torigoe T; Uhara H
    J Dermatol; 2024 Apr; 51(4):e137-e138. PubMed ID: 37997464
    [No Abstract]   [Full Text] [Related]  

  • 10. A case series of cutaneous lymphomas in Mexico.
    Juárez-Villegas LE; Díaz-Salazar Y; Palomo-Collí MÁ; Vega-Real EV; Moctezuma-Juan OLÁ
    Bol Med Hosp Infant Mex; 2020; 77(2):90-93. PubMed ID: 32226002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and prognostic study of primary cutaneous extranodal natural killer/T-cell lymphoma, nasal type: A systematic review.
    Jung JM; Yang HJ; Won CH; Chang SE; Lee MW; Lee WJ
    J Dermatol; 2021 Oct; 48(10):1499-1510. PubMed ID: 34060130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK/T-cell lymphomas in children.
    Lai C; Dunleavy K
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):33-41. PubMed ID: 23768639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updating targets for natural killer/T-cell lymphoma immunotherapy.
    Xue W; Zhang M
    Cancer Biol Med; 2021 Feb; 18(1):52-62. PubMed ID: 33628584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment by using a modified SMILE regimen and autologous hematopoietic stem cell transplantation in a pediatric primary EBV-positive nodular NK/T cell lymphoma patient.
    Li J; Ye J; Wang Y; Wang J; Fang Y
    Ann Hematol; 2022 Feb; 101(2):433-435. PubMed ID: 33580279
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary cutaneous natural killer/T-cell lymphoma presenting as sacrococcygeal and perianal ulcers.
    Ghannem A; Aounallah A; Ghannouchi M; Karim N; Ben Khalifa M; Boudokhan M; Nihed A; Badreddine S; Belajouza C; Denguezli M
    J Cutan Pathol; 2022 Nov; 49(11):925-928. PubMed ID: 34897766
    [No Abstract]   [Full Text] [Related]  

  • 16. A Case of EBV-Negative Aggressive NK-cell Leukemia: Use of Next-Generation Sequencing in Demystifying a Diagnostic Dilemma and Guiding Clinical Care.
    Kennedy VE; Ruiz-Cordero R; Jangam D; Wen KW; Dunavin N; Ohgami RS; Bhargava P; Ai W; Fakhri B
    Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e583-e587. PubMed ID: 33814335
    [No Abstract]   [Full Text] [Related]  

  • 17. Advanced Cutaneous Peripheral T-cell Lymphoma-Not Otherwise Specified with Extensive Ulceronecrotic Dyschromic Plaques and Poor Outcome.
    Sharma V; Bagrodia V
    Turk J Haematol; 2024 Mar; 41(1):43-44. PubMed ID: 37431280
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary neurolymphomatosis in extranodal natural killer/T-cell lymphoma diagnosed by skin biopsy.
    Hsu CH; Yang CS; Chen YJ; Lin TL
    Leuk Lymphoma; 2022 Jan; 63(1):247-249. PubMed ID: 34448429
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematoma-like primary cutaneous peripheral T-cell lymphoma: a rare clinical presentation.
    Mercuri SR; Paolino G; Colombo L; Bearzi P; Bellinzona F; Perrone S; Sassone M; Berti E; Rizzo N
    Ital J Dermatol Venerol; 2021 Dec; 156(Suppl. 1 to No. 6):91-92. PubMed ID: 32057216
    [No Abstract]   [Full Text] [Related]  

  • 20. CD4-positive extranodal NK/T-cell lymphoma with T-cell receptor αβ phenotype.
    Hisamoto T; Miyagaki T; Boki H; Takahashi-Shishido N; Chiba A; Yasunaga M; Mizuno H; Shimura A; Morita K; Sato S
    J Dermatol; 2023 Oct; 50(10):e337-e339. PubMed ID: 37208849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.